Beta-carotene, telomerase activity and Alzheimer's disease in old age subjects.
Aging
Alzheimer’s
Carotenoid
Dementia
Nutrition
Telomerase
Telomeres
Journal
European journal of nutrition
ISSN: 1436-6215
Titre abrégé: Eur J Nutr
Pays: Germany
ID NLM: 100888704
Informations de publication
Date de publication:
Feb 2020
Feb 2020
Historique:
received:
29
06
2018
accepted:
05
01
2019
pubmed:
17
1
2019
medline:
20
11
2020
entrez:
17
1
2019
Statut:
ppublish
Résumé
Advancing age represents the strongest risk factor for Alzheimer's disease (AD), and the identification of biomarkers able to define what characterizes physiological aging from AD may represent a potential starting point for novel preventive strategies. Among these biomarkers, telomeres seem to be a promising target. Interestingly, high intake of carotenoid-rich food may play a role in protecting telomeres by oxidative stress reduction. Accordingly, low plasma β-carotene concentrations have been found in AD subjects when compared with cognitively healthy subjects. In this study, we aim at investigating the hypothesis that low β-carotene might be associated with markers of accelerated cellular aging, including leucocyte telomere length (LTL) and peripheral mononuclear cell (PBMC) telomerase activity in a cohort of old age subjects. The study was conducted in 68 old age subjects, 37 AD, and 31 age-matched healthy controls. In all subjects, β-carotene plasma level, LTL and peripheral telomerase activity were measured. In all populations, β-carotene significantly and positively (r = 0.320, p = 0.008) correlated with telomerase activity, independent of gender. A model having telomerase activity levels as the dependent variable, and age, gender, smoking habit, and β-carotene as independent variables, confirmed that β-carotene was independently associated with telomerase activity (β = 0.319, p = 0.012). Subjects affected by AD had significantly lower plasmatic levels of β-carotene (448 ± 66 mg/ml vs 497 ± 59 mg/ml, p = 0.001) and LTL (0.53 ± 0.25 vs 0.69 ± 0.29; p = 0.009) as compared with healthy controls. Β-carotene plasma level was associated with AD diagnosis (OR 0.988; IC95% 0.978-0.997; p = 0.013) independently of age, gender, smoking habit, ApoE genotype, and LTL. Our data show that β-carotene may modulate telomerase activity in old age. Moreover, lower plasma β-carotene levels, correlating with peripheral telomerase activity, are associated with AD diagnosis independent of multiple covariates.
Identifiants
pubmed: 30649596
doi: 10.1007/s00394-019-01892-y
pii: 10.1007/s00394-019-01892-y
doi:
Substances chimiques
Biomarkers
0
beta Carotene
01YAE03M7J
Telomerase
EC 2.7.7.49
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
119-126Références
Biol Psychiatry. 2006 Sep 1;60(5):432-5
pubmed: 16581033
J Nutr. 2004 Jan;134(1):221S-224S
pubmed: 14704323
Rev Neurol (Paris). 2013 Oct;169(10):744-51
pubmed: 24041475
Curr Opin Cell Biol. 2012 Dec;24(6):739-43
pubmed: 23085234
PLoS One. 2013 Apr 30;8(4):e62781
pubmed: 23646142
J Alzheimers Dis. 2012;31(2):253-8
pubmed: 22543848
Arch Intern Med. 2007 Nov 12;167(20):2184-90
pubmed: 17998490
Circulation. 2009 Jun 2;119(21):2772-80
pubmed: 19451353
Rejuvenation Res. 2007 Mar;10(1):61-74
pubmed: 17378753
Life Sci. 1998;63(11):935-48
pubmed: 9747894
J Alzheimers Dis. 2018;62(3):1319-1335
pubmed: 29562533
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Cell Stem Cell. 2011 Jan 7;8(1):3-4
pubmed: 21211774
Exp Gerontol. 2014 Oct;58:90-5
pubmed: 24975295
J Nutr Health Aging. 2007 May-Jun;11(3):230-7
pubmed: 17508099
Cell. 2013 Jun 6;153(6):1194-217
pubmed: 23746838
Eur J Clin Nutr. 2002 Nov;56(11):1149-54
pubmed: 12428183
Neurobiol Aging. 2004 Sep;25(8):1009-15
pubmed: 15212825
Ageing Res Rev. 2015 Jul;22:1-8
pubmed: 25896211
Nutr Neurosci. 2012 Nov;15(6):244-51
pubmed: 22710805
JAMA. 2002 Jun 26;287(24):3223-9
pubmed: 12076218
JAMA. 1963 Sep 21;185:914-9
pubmed: 14044222
Neuro Endocrinol Lett. 2005 Dec;26(6):696-8
pubmed: 16380679
Dement Geriatr Cogn Disord. 2014;37(3-4):246-56
pubmed: 24247062
Am J Epidemiol. 2013 Jan 1;177(1):33-41
pubmed: 23221724
Nucleic Acids Res. 1988 Feb 11;16(3):1215
pubmed: 3344216
Nucleic Acids Res. 2002 May 15;30(10):e47
pubmed: 12000852
Gerontologist. 1969 Autumn;9(3):179-86
pubmed: 5349366
Front Cell Neurosci. 2014 Apr 22;8:112
pubmed: 24795567
Nature. 2011 Jan 6;469(7328):102-6
pubmed: 21113150
Neurology. 2002 Mar 12;58(5):758-64
pubmed: 11889240
Ageing Res Rev. 2017 Nov;40:84-94
pubmed: 28941639
Cell. 2008 Nov 14;135(4):609-22
pubmed: 19013273
Eur J Nutr. 2017 Apr;56(3):1045-1052
pubmed: 26818530
Mol Aspects Med. 2005 Dec;26(6):459-516
pubmed: 16309738
Circ Res. 2006 Jul 21;99(2):156-64
pubmed: 16794190
Immunol Rev. 1997 Dec;160:43-54
pubmed: 9476664
JAMA Neurol. 2014 Jul 1;71(7):921-3
pubmed: 25023551
J Alzheimers Dis. 2015;46(3):761-9
pubmed: 26402514
J Gerontol A Biol Sci Med Sci. 2006 Jun;61(6):616-20
pubmed: 16799145
Ann N Y Acad Sci. 2002 Apr;959:24-9
pubmed: 11976182
Neurobiol Aging. 2003 Nov;24(7):915-9
pubmed: 12928050
Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17312-5
pubmed: 15574496
Neurology. 1996 Mar;46(3):700-6
pubmed: 8618670
EMBO Mol Med. 2012 Aug;4(8):691-704
pubmed: 22585399
Ageing Res Rev. 2014 May;15:1-5
pubmed: 24561251
Nutr Clin Care. 2002 Mar-Apr;5(2):56-65
pubmed: 12134711